Business Value Formula:
| From: | To: |
The business value formula using discounted cash flow method calculates the intrinsic value of a company by dividing the free cash flow to the firm (FCFF) by the weighted average cost of capital (WACC). This approach provides a fundamental valuation based on the company's ability to generate cash flows.
The calculator uses the business value formula:
Where:
Explanation: This formula represents a simplified perpetuity model where FCFF is assumed to grow at a constant rate equal to zero, making it suitable for stable, mature companies.
Details: Accurate business valuation is crucial for investment decisions, mergers and acquisitions, financial reporting, and strategic planning. It helps investors determine whether a company is overvalued or undervalued in the market.
Tips: Enter FCFF in currency units and WACC as a percentage. Both values must be positive (FCFF > 0, WACC > 0). For more accurate valuations, consider using multi-period DCF models.
Q1: What is FCFF and how is it different from FCFE?
A: FCFF (Free Cash Flow to Firm) represents cash available to all investors (debt and equity), while FCFE (Free Cash Flow to Equity) represents cash available only to equity shareholders after debt obligations.
Q2: How do I determine the appropriate WACC for a company?
A: WACC is calculated using the formula: WACC = (E/V × Re) + (D/V × Rd × (1 - Tc)), where E is equity, D is debt, V is total value, Re is cost of equity, Rd is cost of debt, and Tc is tax rate.
Q3: When is this simplified valuation model most appropriate?
A: This model works best for mature, stable companies with predictable cash flows and constant capital structure. For growth companies, multi-stage DCF models are more suitable.
Q4: What are the limitations of this valuation approach?
A: Limitations include the assumption of perpetual constant cash flows, sensitivity to WACC estimates, and not accounting for growth opportunities or changing risk profiles.
Q5: How does this compare to other valuation methods?
A: DCF valuation is considered more fundamental than relative valuation methods (P/E, EV/EBITDA) as it focuses on intrinsic value rather than market comparisons.